{"timestamp": "2025-08-01T05:00:28.433744Z", "run_id": "run_549857643b0d4bcd9ce89f308ac9d10f", "workflow_name": "Domain Extraction Debug", "task_key": "deconstruct_problem", "action_type": "generate_text_llm", "attempt": 1, "duration_sec": 4.5892, "inputs": {"prompt": "Analyze the following problem and deconstruct it into core components:\n\nI am the CEO of a publicly traded pharmaceutical company. We have developed a life-saving drug that could help millions, but our pricing strategy is under intense scrutiny.\n\nIdentify:\n1. Core domain areas\n2. Key variables and unknowns\n3. Strategic requirements\n4. Risk factors\n5. Success criteria\n\nOutput your analysis as a structured JSON object with a key 'deconstruction_text'.", "model": "gemini-1.5-flash-latest", "max_tokens": 2000, "temperature": 0.3}, "result": {"result": {"response_text": "```json\n{\n  \"deconstruction_text\": {\n    \"1. Core Domain Areas\": [\n      \"Pharmaceutical Development & Manufacturing\",\n      \"Pricing & Market Access\",\n      \"Regulatory Affairs (FDA, EMA etc.)\",\n      \"Public Relations & Corporate Communications\",\n      \"Financial Management & Investment\",\n      \"Healthcare Economics & Policy\",\n      \"Ethics & Social Responsibility\"\n    ],\n    \"2. Key Variables and Unknowns\": [\n      \"Drug efficacy and safety profile in diverse populations\",\n      \"Manufacturing capacity and scalability\",\n      \"Market size and potential patient reach\",\n      \"Competitor landscape and alternative treatments\",\n      \"Public and political sentiment towards drug pricing\",\n      \"Regulatory approval timelines and conditions\",\n      \"Insurance coverage and reimbursement rates\",\n      \"Patient affordability and access\",\n      \"Long-term cost-effectiveness compared to existing treatments\",\n      \"Potential for generic competition\",\n      \"Impact of pricing on company profitability and shareholder value\"\n    ],\n    \"3. Strategic Requirements\": [\n      \"Develop a transparent and justifiable pricing strategy\",\n      \"Ensure equitable access to the drug for patients in need\",\n      \"Maximize shareholder value while maintaining ethical standards\",\n      \"Manage public perception and address concerns about affordability\",\n      \"Navigate complex regulatory landscapes and obtain necessary approvals\",\n      \"Secure reimbursement from payers (insurance companies, governments)\",\n      \"Build strong relationships with key stakeholders (patients, doctors, payers, regulators)\",\n      \"Develop a robust communication plan to address public concerns\"\n    ],\n    \"4. Risk Factors\": [\n      \"Negative public and media reaction to pricing\",\n      \"Government price controls or regulations\",\n      \"Failure to secure sufficient reimbursement from payers\",\n      \"Competition from cheaper alternatives\",\n      \"Manufacturing delays or disruptions\",\n      \"Adverse events or safety concerns after market launch\",\n      \"Reputational damage impacting brand trust\",\n      \"Legal challenges related to pricing or marketing\",\n      \"Financial losses due to underpricing or low sales\",\n      \"Ethical dilemmas related to balancing profitability and access\"\n    ],\n    \"5. Success Criteria\": [\n      \"Successful regulatory approval and market launch\",\n      \"Achieving a high level of patient access\",\n      \"Generating sufficient revenue to sustain the company and fund future research\",\n      \"Maintaining a positive public image and strong brand reputation\",\n      \"Meeting ethical standards and demonstrating social responsibility\",\n      \"Achieving a positive return on investment for shareholders\",\n      \"Demonstrating long-term cost-effectiveness compared to existing treatments\"\n    ]\n  }\n}\n```"}, "reflection": {"action_name": "generate_text", "timestamp_utc": 1754024433.0228496, "status": "Success", "confidence": 0.9, "summary_message": "Text generation completed successfully using gemini-1.5-flash-latest.", "inputs_preview": {"prompt": "Analyze the following problem and deconstruct it into core components:\n\nI am the CEO of a publicly t...", "model": "gemini-1.5-flash-latest", "max_tokens": "2000", "temperature": "0.3"}, "outputs_preview": {"response_text": "```json\n{\n  \"deconstruction_text\": {\n    \"1. Core Domain Areas\": [\n      \"Pharmaceutical Development..."}, "alignment_check": {"resonatia_protocol": "Alignment not assessed."}, "potential_issues": [], "execution_time_seconds": 4.588719844818115}}}
{"timestamp": "2025-08-01T05:00:33.023503Z", "run_id": "run_549857643b0d4bcd9ce89f308ac9d10f", "workflow_name": "Domain Extraction Debug", "task_key": "extract_domain_from_deconstruction", "action_type": "generate_text_llm", "attempt": 1, "duration_sec": 0.5114, "inputs": {"prompt": "From the following JSON analysis, identify and extract only the single, most relevant 'Core domain area'. Your output must be a single, clean JSON object with one key: 'domain'. For example: {\"domain\": \"Artificial Intelligence Strategy\"}\n\nAnalysis:\n```json\n{\n  \"deconstruction_text\": {\n    \"1. Core Domain Areas\": [\n      \"Pharmaceutical Development & Manufacturing\",\n      \"Pricing & Market Access\",\n      \"Regulatory Affairs (FDA, EMA etc.)\",\n      \"Public Relations & Corporate Communications\",\n      \"Financial Management & Investment\",\n      \"Healthcare Economics & Policy\",\n      \"Ethics & Social Responsibility\"\n    ],\n    \"2. Key Variables and Unknowns\": [\n      \"Drug efficacy and safety profile in diverse populations\",\n      \"Manufacturing capacity and scalability\",\n      \"Market size and potential patient reach\",\n      \"Competitor landscape and alternative treatments\",\n      \"Public and political sentiment towards drug pricing\",\n      \"Regulatory approval timelines and conditions\",\n      \"Insurance coverage and reimbursement rates\",\n      \"Patient affordability and access\",\n      \"Long-term cost-effectiveness compared to existing treatments\",\n      \"Potential for generic competition\",\n      \"Impact of pricing on company profitability and shareholder value\"\n    ],\n    \"3. Strategic Requirements\": [\n      \"Develop a transparent and justifiable pricing strategy\",\n      \"Ensure equitable access to the drug for patients in need\",\n      \"Maximize shareholder value while maintaining ethical standards\",\n      \"Manage public perception and address concerns about affordability\",\n      \"Navigate complex regulatory landscapes and obtain necessary approvals\",\n      \"Secure reimbursement from payers (insurance companies, governments)\",\n      \"Build strong relationships with key stakeholders (patients, doctors, payers, regulators)\",\n      \"Develop a robust communication plan to address public concerns\"\n    ],\n    \"4. Risk Factors\": [\n      \"Negative public and media reaction to pricing\",\n      \"Government price controls or regulations\",\n      \"Failure to secure sufficient reimbursement from payers\",\n      \"Competition from cheaper alternatives\",\n      \"Manufacturing delays or disruptions\",\n      \"Adverse events or safety concerns after market launch\",\n      \"Reputational damage impacting brand trust\",\n      \"Legal challenges related to pricing or marketing\",\n      \"Financial losses due to underpricing or low sales\",\n      \"Ethical dilemmas related to balancing profitability and access\"\n    ],\n    \"5. Success Criteria\": [\n      \"Successful regulatory approval and market launch\",\n      \"Achieving a high level of patient access\",\n      \"Generating sufficient revenue to sustain the company and fund future research\",\n      \"Maintaining a positive public image and strong brand reputation\",\n      \"Meeting ethical standards and demonstrating social responsibility\",\n      \"Achieving a positive return on investment for shareholders\",\n      \"Demonstrating long-term cost-effectiveness compared to existing treatments\"\n    ]\n  }\n}\n```", "model": "gemini-1.5-flash-latest", "max_tokens": 100, "temperature": 0.1}, "result": {"result": {"response_text": "```json\n{\"domain\": \"Pharmaceutical Development & Manufacturing\"}\n```"}, "reflection": {"action_name": "generate_text", "timestamp_utc": 1754024433.5348942, "status": "Success", "confidence": 0.9, "summary_message": "Text generation completed successfully using gemini-1.5-flash-latest.", "inputs_preview": {"prompt": "From the following JSON analysis, identify and extract only the single, most relevant 'Core domain a...", "model": "gemini-1.5-flash-latest", "max_tokens": "100", "temperature": "0.1"}, "outputs_preview": {"response_text": "```json\n{\"domain\": \"Pharmaceutical Development & Manufacturing\"}\n```"}, "alignment_check": {"resonatia_protocol": "Alignment not assessed."}, "potential_issues": [], "execution_time_seconds": 0.5083699226379395}}}
{"timestamp": "2025-08-01T05:00:33.535034Z", "run_id": "run_549857643b0d4bcd9ce89f308ac9d10f", "workflow_name": "Domain Extraction Debug", "task_key": "debug_domain_output", "action_type": "execute_code", "attempt": 1, "duration_sec": 0.0435, "inputs": {"language": "python", "code": "import json\nprint('=== DEBUG DOMAIN OUTPUT ===')\nprint('Raw domain task result:')\nprint(repr({\"result\": {\"response_text\": \"```json\\n{\\\"domain\\\": \\\"Pharmaceutical Development & Manufacturing\\\"}\\n```\"}, \"reflection\": {\"action_name\": \"generate_text\", \"timestamp_utc\": 1754024433.5348942, \"status\": \"Success\", \"confidence\": 0.9, \"summary_message\": \"Text generation completed successfully using gemini-1.5-flash-latest.\", \"inputs_preview\": {\"prompt\": \"From the following JSON analysis, identify and extract only the single, most relevant 'Core domain a...\", \"model\": \"gemini-1.5-flash-latest\", \"max_tokens\": \"100\", \"temperature\": \"0.1\"}, \"outputs_preview\": {\"response_text\": \"```json\\n{\\\"domain\\\": \\\"Pharmaceutical Development & Manufacturing\\\"}\\n```\"}, \"alignment_check\": {\"resonatia_protocol\": \"Alignment not assessed.\"}, \"potential_issues\": [], \"execution_time_seconds\": 0.5083699226379395}, \"response_text\": \"```json\\n{\\\"domain\\\": \\\"Pharmaceutical Development & Manufacturing\\\"}\\n```\", \"output\": \"```json\\n{\\\"domain\\\": \\\"Pharmaceutical Development & Manufacturing\\\"}\\n```\", \"parsed_json\": {\"domain\": \"Pharmaceutical Development & Manufacturing\"}, \"domain\": \"Pharmaceutical Development & Manufacturing\"}))\nprint('\\nDomain output field:')\nprint(repr(```json\n{\"domain\": \"Pharmaceutical Development & Manufacturing\"}\n```))\nprint('\\nTrying to access domain field:')\ntry:\n    domain_value = null\n    print(f'Domain value: {repr(domain_value)}')\nexcept Exception as e:\n    print(f'Error accessing domain: {e}')\nprint('=== END DEBUG ===')"}, "result": {"result": {"output": "", "error": "  File \"/tmp/tmpbq4ydnca.python\", line 6\n    print(repr(```json\n               ^\nSyntaxError: invalid syntax\n"}, "reflection": {"action_name": "execute_code", "timestamp_utc": 1754024433.578382, "status": "Failure", "confidence": 0.1, "summary_message": "Code execution failed with return code 1.", "inputs_preview": {"language": "python", "code": "import json\nprint('=== DEBUG DOMAIN OUTPUT ===')\nprint('Raw domain task result:')\nprint(repr({\"resul..."}, "outputs_preview": {"output": "", "error": "  File \"/tmp/tmpbq4ydnca.python\", line 6\n    print(repr(```json\n               ^\nSyntaxError: invali..."}, "alignment_check": {"resonatia_protocol": "Alignment not assessed."}, "potential_issues": ["Return Code: 1", "  File \"/tmp/tmpbq4ydnca.python\", line 6\n    print(repr(```json\n               ^\nSyntaxError: invalid syntax\n"], "execution_time_seconds": 0.04299664497375488}}}
